Description
Allertek (mometasone furoate) Nazo Nasal Spray 50 mcg/dose, 60 doses vial
Ingredients
Active ingredient: Mometasone furoate. Other ingredients include benzalkonium chloride, sodium citrate, citric acid, and purified water.
Mechanism of Action
Mometasone furoate, a corticosteroid, exerts anti-inflammatory and vasoconstrictive effects by inhibiting the release of inflammatory mediators. It reduces nasal symptoms such as congestion, itching, and sneezing by suppressing the inflammatory response in the nasal mucosa.
Pharmacological Properties
Mometasone furoate acts locally in the nasal mucosa to reduce inflammation and symptoms associated with allergic rhinitis. It has minimal systemic absorption, decreasing the risk of systemic side effects.
Indications for Use
Indicated for: Treatment of nasal symptoms associated with allergic rhinitis in adults and children 2 years of age and older.
Contraindications
Contraindications: Do not use in patients with a known hypersensitivity to mometasone furoate or any of the ingredients in the product.
Side Effects
Common side effects may include nasal irritation, epistaxis (nosebleeds), headache, and pharyngitis. Rarely, systemic effects such as adrenal suppression or glaucoma may occur with prolonged use.
Usage Instructions
Usage instructions: Shake well before each use. Prime the spray pump before the first use. Insert the nozzle into one nostril while closing the other nostril. Press down on the pump to release the spray while inhaling gently through the nose.
Benefits Compared to Analogues
Allertek nasal spray offers the advantage of once-daily dosing, convenient administration, and proven efficacy in managing allergic rhinitis symptoms. Its corticosteroid formulation provides potent anti-inflammatory effects with minimal systemic absorption, reducing the risk of systemic side effects compared to some other nasal sprays.
Suitable Patient Groups
Allertek is suitable for use in both pediatric and adult populations, including children as young as 2 years old and elderly patients. Its low systemic absorption and local action make it a suitable option for long-term management of allergic rhinitis in various age groups.
Storage and Shelf Life
- Storage: Store at controlled room temperature between 20°C to 25°C (68°F to 77°F). Protect from light.
- Shelf Life: Check the product label for the expiration date. Do not use the product after the specified date.
Packaging Description
Allertek nasal spray is supplied in a 60 doses vial, each delivering 50 mcg of mometasone furoate per dose. The packaging is designed to maintain product integrity and ensure accurate dosing with each use.
Clinical Evidence and Proven Effectiveness
Pharmacological effects: Mometasone furoate, a corticosteroid, exerts anti-inflammatory and vasoconstrictive effects by inhibiting the release of inflammatory mediators. It reduces nasal symptoms such as congestion, itching, and sneezing by suppressing the inflammatory response in the nasal mucosa.
Clinical trials: Clinical studies have demonstrated the efficacy of mometasone furoate nasal spray in improving nasal symptoms and quality of life in patients with allergic rhinitis. Research by Meltzer et al. (2011) showed significant improvements in nasal congestion and sneezing compared to placebo.
Additional Information
- Warnings: Avoid spraying into eyes. If irritation or sensitization occurs, discontinue use and consult a healthcare provider.
